Verapamil acute administration: a new dynamic test in hyperprolactinemic states.

Barbaro, D; Faggionato, F; Pallini, S; Carnesecchi, C; Palla, A; Bombara, M; Falciani, C; La Gioia, A; Loni, G

Barbaro, D; Faggionato, F; Pallini, S; Carnesecchi, C; Palla, A; Bombara, M; Falciani, C; La Gioia, A; Loni, G.

Affiliation

Barbaro D; Second Medicina Generale-Endocrinologia, Unità Operativa Neurochirurgia, First Medicina Generale, Livorno, Italia.

Metabolism ; 48(11): 1351-6, 1999 Nov.

Article in En | MEDLINE | ID: mdl-10582540

Subject(s)

Calcium Channel Blockers/administration & dosage; Calcium Channel Blockers/pharmacology; Hyperprolactinemia/blood; Prolactin/blood; Prolactinoma/complications; Verapamil/administration & dosage; Verapamil/pharmacology; Administration, Oral; Chemistry, Pharmaceutical; Humans; Hyperprolactinemia/etiology; Infusions, Intravenous; Prolactinoma/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prolactin / Hyperprolactinemia / Calcium Channel Blockers / Verapamil / Prolactinoma Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Metabolism Year: 1999 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links